Pre-reading - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

中文

Home

AT CBS

•　General Information •　Welcome Message •　Association and Affiliations •　Contact Us

Faculty

•　Course Directors •　Director of Consultative Commi •　Director of Academic Committee •　Members of Academic Committee •　General Secretary •　International Faculty •　Hong Kong and Taiwan Faculty •　Domestic Faculty

Program

•　Program at a Glance •　Program Search

Events

•　Slides •　Photos •　Interviews •　Videos

Scientific Library

•　Abstract

•　Acute Myocardial Infarction

•　Bifurcation Stenting

•　Cardio-oncology

•　Congestive Heart Failure

•　DAPT Duration

•　Drug Coated Balloon

•　Fractional Flow Reserve

•　IVUS Guidance

•　Optical Coherence Tomography

•　Pulmonary Hypertension

•　Rotational Atherectomy

•　Shear Stress

•　Stenting Left Main

•　Recommeded Article •　Top 10 Literature

Registration

•　Registration Information •　Faculty Registration •　International Registration

History

•　CBS2016 •　CBS2015 •　CBS2014 •　CBS2013 •　CBS2012

Home < Pre-reading <

Pre-reading

Abstract

|<< 1 2 3 4 5 6 7 8 >>|

Original Research

JOURNAL：CBSMD

Advances in Chronic Thromboembolic Pulmonary Hypertension

CBSMD

Pre-reading

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary embolism and a major cause of chronic PH leading to right heart failure and death. Lung ventilation/perfusion scintigraphy is the screening test of choice; a normal scan rules out CTEPH. In the case of an abnormal perfusion scan, a high-quality pulmonary angiogram is necessary to confirm and define the pulmonary vascular involvement and prior to making a treatment decision. PH is confirmed with right heart catheterisation, which is also necessary for treatment determination. In addition to chronic anticoagulation therapy, each patient with CTEPH should receive treatment assessment starting with evaluation for pulmonary endarterectomy, which is the guideline recommended treatment. For technically inoperable cases, PH-targeted medical therapy is recommended (currently riociguat based on the CHEST studies), and balloon pulmonary angioplasty should be considered at a centre experienced with this challenging but potentially effective and complementary intervention.

New advances in the research field "CTEPH" are listed in this pre-reading article.